
Sign up to save your podcasts
Or


Medical innovation is often hindered by the high costs of clinical trials and the complexity of navigating government regulations and reporting requirements. For many companies, this prevents life-saving advances from reaching the market. Now, there is a way to accelerate human clinical trials and reduce development expenses. This represents one of the positive aspects of globalization. Julio Martinez-Clark, CEO of Bioaccess, is here today.
Key Takeaways To Tune In For:
(04:40) - Challenges of US Clinical Trials
(08:33) - Why Startups Look Overseas
(19:00) - Real-World Success Stories
(23:01) - Panama's Role in Innovation
(27:49) - Global Trial Accelerators Podcast
Resources talked about in this episode:
Website:
juliomartinezclark.com
bioaccessla.com
Podcast: Global Trial Accelerators
Social media handles: LinkedIn
By Dr. John Neustadt5
1818 ratings
Medical innovation is often hindered by the high costs of clinical trials and the complexity of navigating government regulations and reporting requirements. For many companies, this prevents life-saving advances from reaching the market. Now, there is a way to accelerate human clinical trials and reduce development expenses. This represents one of the positive aspects of globalization. Julio Martinez-Clark, CEO of Bioaccess, is here today.
Key Takeaways To Tune In For:
(04:40) - Challenges of US Clinical Trials
(08:33) - Why Startups Look Overseas
(19:00) - Real-World Success Stories
(23:01) - Panama's Role in Innovation
(27:49) - Global Trial Accelerators Podcast
Resources talked about in this episode:
Website:
juliomartinezclark.com
bioaccessla.com
Podcast: Global Trial Accelerators
Social media handles: LinkedIn

7,290 Listeners

113,290 Listeners

729 Listeners

494 Listeners

3,413 Listeners

3,472 Listeners

9,242 Listeners

8,049 Listeners

768 Listeners

2,136 Listeners